Chemport Inc, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is EPA960EE (ICOSAPENT ETHYL), with a corresponding US DMF Number 38013.
Remarkably, this DMF maintains an Active status since its submission on February 13, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2024, and payment made on August 17, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II